82 related articles for article (PubMed ID: 18986009)
1. Intravenous iron sucrose does not impair sonographic brachial vasodilation in peritoneal dialysis patients.
Bolaños L; González-Juanatey C; Testa A; Ranero R
Adv Perit Dial; 2008; 24():90-5. PubMed ID: 18986009
[TBL] [Abstract][Full Text] [Related]
2. Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects.
Zheng H; Huang X; Zhang Q; Katz SD
Kidney Int; 2006 Feb; 69(4):679-84. PubMed ID: 16395269
[TBL] [Abstract][Full Text] [Related]
3. Acute and subacute effects of EV iron sucrose on endothelial functions in hemodialysis patients.
Ozkurt S; Ozenc F; Degirmenci NA; Temiz G; Musmul A; Sahin G; Yalcin AU
Ren Fail; 2012; 34(1):1-6. PubMed ID: 22017464
[TBL] [Abstract][Full Text] [Related]
4. Intravenous iron increases labile serum iron but does not impair forearm blood flow reactivity in dialysis patients.
Schaller G; Scheiber-Mojdehkar B; Wolzt M; Puttinger H; Mittermayer F; Hörl WH; Födinger M; Sunder-Plassmann G; Vychytil A
Kidney Int; 2005 Dec; 68(6):2814-22. PubMed ID: 16316358
[TBL] [Abstract][Full Text] [Related]
5. Endothelial dysfunction and oxidative stress in chronic renal failure.
Ghiadoni L; Cupisti A; Huang Y; Mattei P; Cardinal H; Favilla S; Rindi P; Barsotti G; Taddei S; Salvetti A
J Nephrol; 2004; 17(4):512-9. PubMed ID: 15372412
[TBL] [Abstract][Full Text] [Related]
6. Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis.
Pai AB; Boyd AV; McQuade CR; Harford A; Norenberg JP; Zager PG
Pharmacotherapy; 2007 Mar; 27(3):343-50. PubMed ID: 17316146
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress in hemodialysis patients receiving intravenous iron therapy and the role of N-acetylcysteine in preventing oxidative stress.
Swarnalatha G; Ram R; Neela P; Naidu MU; Dakshina Murty KV
Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):852-8. PubMed ID: 20814119
[TBL] [Abstract][Full Text] [Related]
8. Improvement of endothelial function in uraemic patients on peritoneal dialysis: a possible role for 5-MTHF administration.
Baragetti I; Raselli S; Stucchi A; Terraneo V; Furiani S; Buzzi L; Garlaschelli K; Alberghini E; Catapano AL; Buccianti G
Nephrol Dial Transplant; 2007 Nov; 22(11):3292-7. PubMed ID: 17595187
[TBL] [Abstract][Full Text] [Related]
9. [The effect of gender on vasomotor function of the vascular endothelium and cardiovascular remodelling during aging].
Bojić M; Djurić D; Petrović J; Popović Z; Tasić N; Petrović B; Djurić A; Bojić D; Plećas B; Mitrović V; Kanjuh V
Srp Arh Celok Lek; 1999; 127(3-4):101-8. PubMed ID: 10500433
[TBL] [Abstract][Full Text] [Related]
10. Effect of fluvastatin on endothelium-dependent brachial artery vasodilation in patients after renal transplantation.
Hausberg M; Kosch M; Stam F; Heidenreich S; Kisters K; Rahn KH; Barenbrock M
Kidney Int; 2001 Apr; 59(4):1473-9. PubMed ID: 11260410
[TBL] [Abstract][Full Text] [Related]
11. Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease.
Pannier B; Guerin AP; Marchais SJ; Metivier F; Safar ME; London GM
Kidney Int; 2000 Mar; 57(3):1091-9. PubMed ID: 10720961
[TBL] [Abstract][Full Text] [Related]
12. Vitamin C improves resistance but not conduit artery endothelial function in patients with chronic renal failure.
Cross JM; Donald AE; Nuttall SL; Deanfield JE; Woolfson RG; Macallister RJ
Kidney Int; 2003 Apr; 63(4):1433-42. PubMed ID: 12631359
[TBL] [Abstract][Full Text] [Related]
13. Flow-mediated vasodilation and distensibility of the brachial artery in renal allograft recipients.
Hausberg M; Kisters K; Kosch M; Rahn KH; Barenbrock M
Kidney Int; 1999 Mar; 55(3):1104-10. PubMed ID: 10027950
[TBL] [Abstract][Full Text] [Related]
14. Randomized clinical trial on acute effects of i.v. iron sucrose during haemodialysis.
Garcia-Fernandez N; Echeverria A; Sanchez-Ibarrola A; Páramo JA; Coma-Canella I
Nephrology (Carlton); 2010 Mar; 15(2):178-83. PubMed ID: 20470276
[TBL] [Abstract][Full Text] [Related]
15. Effects of losartan + L-arginine on nitric oxide production, endothelial cell function, and hemodynamic variables in patients with heart failure secondary to coronary heart disease.
Koifman B; Topilski I; Megidish R; Zelmanovich L; Chernihovsky T; Bykhovsy E; Keren G
Am J Cardiol; 2006 Jul; 98(2):172-7. PubMed ID: 16828587
[TBL] [Abstract][Full Text] [Related]
16. Androgen deficiency and endothelial dysfunction in men with end-stage kidney disease receiving maintenance hemodialysis.
Karakitsos D; Patrianakos AP; De Groot E; Boletis J; Karabinis A; Kyriazis J; Samonis G; Parthenakis FI; Vardas PE; Daphnis E
Am J Nephrol; 2006; 26(6):536-43. PubMed ID: 17159341
[TBL] [Abstract][Full Text] [Related]
17. Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-brachial artery reactivity study).
Papaioannou GI; Seip RL; Grey NJ; Katten D; Taylor A; Inzucchi SE; Young LH; Chyun DA; Davey JA; Wackers FJ; Iskandrian AE; Ratner RE; Robinson EC; Carolan S; Engel S; Heller GV
Am J Cardiol; 2004 Aug; 94(3):294-9. PubMed ID: 15276091
[TBL] [Abstract][Full Text] [Related]
18. Acute injury with intravenous iron and concerns regarding long-term safety.
Bishu K; Agarwal R
Clin J Am Soc Nephrol; 2006 Sep; 1 Suppl 1():S19-23. PubMed ID: 17699372
[TBL] [Abstract][Full Text] [Related]
19. Two different modalities of iron gluconate i.v. administration: effects on iron, oxidative and inflammatory status in peritoneal dialysis patients.
de Vecchi AF; Novembrino C; Lonati S; Ippolito S; Bamonti F
Nephrol Dial Transplant; 2007 Jun; 22(6):1709-13. PubMed ID: 17298995
[TBL] [Abstract][Full Text] [Related]
20. Acute administration of L-arginine does not improve arterial endothelial function in chronic renal failure.
Cross JM; Donald AE; Kharbanda R; Deanfield JE; Woolfson RG; MacAllister RJ
Kidney Int; 2001 Dec; 60(6):2318-23. PubMed ID: 11737605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
